NetworkNewsBreaks – Earth Science Tech, Inc. (ET
Post# of 333
(Total Views: 245)
Posted On: 07/10/2018 5:04:59 PM
NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Provides Update on CBD Patent Formulas
Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, this morning issued a release detailing the progression of the company’s CBD IP patent formula development program. The company is currently developing three new CBD formulas, one of which is a new type of superfood with unique organoleptic properties that is formulated from a mix of hemp oil and other vegetable oil(s) and enriched with a highly potent antioxidant. This product is designed to improve the individual’s antioxidant ingestion. The remaining two unique CBD formula products are comprised of a neuron protector and a breast protector which both proved very promising in R&D performed by the Centre de développement bioalimentaire du Québec (“CDBQ”) or Quebec Agrifood Innovation Center (“QAIC”). Additionally, the company has two products in development as part of a joint venture with Bionatus Laboratório Botânico of Brazil and its Canadian division, Bionatus Botanical Laboratories, Inc. “We are already at work with Bionatus in Brazil and in Canada on the manufacture of the first product, Propovit enriched with ETST hemp oil. We are also working on a reformulation of Bionatus’ product,” ETST CEO and Chief Science Officer, Dr. Michel Aube stated in the news release. “The new formulation will see the product enriched with CBD to boost the suspected anti-inflammatory and bronchial-dilatation properties of the main natural ingredient – Guaco (Mikania glomerata) extract.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, this morning issued a release detailing the progression of the company’s CBD IP patent formula development program. The company is currently developing three new CBD formulas, one of which is a new type of superfood with unique organoleptic properties that is formulated from a mix of hemp oil and other vegetable oil(s) and enriched with a highly potent antioxidant. This product is designed to improve the individual’s antioxidant ingestion. The remaining two unique CBD formula products are comprised of a neuron protector and a breast protector which both proved very promising in R&D performed by the Centre de développement bioalimentaire du Québec (“CDBQ”) or Quebec Agrifood Innovation Center (“QAIC”). Additionally, the company has two products in development as part of a joint venture with Bionatus Laboratório Botânico of Brazil and its Canadian division, Bionatus Botanical Laboratories, Inc. “We are already at work with Bionatus in Brazil and in Canada on the manufacture of the first product, Propovit enriched with ETST hemp oil. We are also working on a reformulation of Bionatus’ product,” ETST CEO and Chief Science Officer, Dr. Michel Aube stated in the news release. “The new formulation will see the product enriched with CBD to boost the suspected anti-inflammatory and bronchial-dilatation properties of the main natural ingredient – Guaco (Mikania glomerata) extract.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)